The Patent Finder

Achillion Pharmaceuticals, Inc.

51 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

2
Ending by 2030
Jun 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Phosphonate Compounds for Treatment of Complement Mediated Disorders (US 10,301,336) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 1 fee due Jan 25, 2027
    The maintenance fee for Aryl, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders (US 11,708,351) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 3 fees due Feb 6 to 20, 2027 · next Feb 6
  • 2 fees due Apr 1, 2027
  • 4 fees due May 5 to 14, 2027 · next May 5
  • 1 fee due Aug 4, 2027
    The maintenance fee for Ether Compounds for Treatment of Complement Mediated Disorders (US 10,550,140) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 1 fee due Sep 12, 2027
    The maintenance fee for Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders (US 11,926,617) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 5 terms have ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,902,365Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,044,2048-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,614,1804-amino-4-oxobutanoyl peptides as inhibitors of viral replication
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,695,205Amide Compounds for Treatment of Complement Mediated Disorders
In force
 · High confidence
In forceHigh confidence
US 9,732,103Carbamate, Ester, and Ketone Compounds for Treatment of Complement Mediated Disorders
In force
 · High confidence
In forceHigh confidence
US 9,732,104Ether Compounds for Treatment of Complement Mediated Disorders
In force
 · High confidence
In forceHigh confidence
US 10,081,645Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders
In force
 · High confidence
In forceHigh confidence
US 10,189,869Amino Compounds for Treatment of Complement Mediated Disorders
In force
 · Medium confidence
In forceMedium confidence
US 10,253,053Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders
In force
 · High confidence
In forceHigh confidence
US 10,301,336Phosphonate Compounds for Treatment of Complement Mediated Disorders
In force
 · Medium confidence
In forceMedium confidence
10 of 51 patents shown.
Pro members see all 51.
Pro members: see all 51 patents
Also on record, not counted in the 51: 52 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 12 abandoned · 27 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited